Exicure

XCUR · NASDAQ

$0.9987−$0.0313 (−3.04%)TodayMarket closed · Oct 20, 7:07 PM ET

Prev close $1.03

Latest news

NewsAug 21, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsAug 17, 5:06 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsJul 16, 8:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsJul 15, 5:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsJun 4, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsMay 29, 5:36 PM ET
Exicure Q1 EPS $(0.29) Down From $0.49 YoY
Press releaseApr 22, 7:54 PM ETGlobe Newswire
Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
NewsApr 9, 8:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsDec 15, 8:06 AM ETAvi Kapoor
Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session
NewsDec 15, 4:54 AM ETAvi Kapoor
Why MindWalk Holdings Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
NewsDec 9, 12:11 PM ETAvi Kapoor
Crude Oil Down 1%; AutoZone Shares Dip After Q1 Results
NewsDec 9, 12:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsDec 9, 11:39 AM ETVandana Singh
Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial
NewsDec 9, 9:43 AM ETAvi Kapoor
Dow Surges Over 100 Points; Campbell's Posts Upbeat Earnings
NewsDec 9, 7:21 AM ET
Market-Moving News for December 9th
NewsNov 21, 7:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
Press releaseOct 22, 4:15 PM ETBusiness Wire
Halper Sadeh LLC Encourages Exicure, Inc. Shareholders to Contact the Firm to Discuss Their Rights
NewsOct 6, 7:04 AM ET
Exicure Says Ongoing Phase 2 Study Of Burixafor In Autologous Stem Cell Transplant For Multiple Myeloma Nears Key Readout
Press releaseOct 6, 7:00 AM ETGlobe Newswire
Exicure Highlights Recent Achievements and Near-term Strategic Priorities
Press releaseAug 8, 4:01 PM ETBusiness Wire
Exicure, Inc. Reports Second Quarter 2025 Financial Results
Press releaseAug 4, 4:37 PM ETBusiness Wire
Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements
Press releaseAug 1, 4:01 PM ETBusiness Wire
Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant
Press releaseJun 27, 4:01 PM ETBusiness Wire
Exicure, Inc. Reports First Quarter 2025 Financial Results
Press releaseMay 28, 4:58 PM ETBusiness Wire
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
Press releaseMay 5, 8:00 AM ETBusiness Wire
Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant
Press releaseApr 14, 6:11 PM ETBusiness Wire
Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma
Press releaseApr 11, 7:42 PM ETBusiness Wire
Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)
NewsMar 18, 5:05 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseMar 18, 4:01 PM ETBusiness Wire
Exicure, Inc. Reports Full Year 2024 Financial Results
Press releaseMar 13, 4:08 PM ETBusiness Wire
Exicure, Inc. (Nasdaq: XCUR) Announces Issuance of New Patent in Australia
NewsMar 13, 8:09 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsFeb 7, 7:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
Press releaseJan 22, 4:01 PM ETBusiness Wire
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
Press releaseDec 26, 8:08 PM ETBusiness Wire
Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech
NewsDec 20, 5:11 PM ET
Exicure Announces Shareholders Approve $8.7M Equity Financing From HiTron Systems
Press releaseDec 20, 4:42 PM ETBusiness Wire
Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
NewsDec 4, 5:11 AM ETAvi Kapoor
Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
NewsNov 25, 4:05 PM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsNov 20, 4:10 PM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseNov 14, 4:01 PM ETBusiness Wire
Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results
NewsOct 31, 12:34 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsSep 19, 5:26 AM ETAvi Kapoor
Why Exicure Shares Are Trading Higher By Around 180%; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Exicure Q1 EPS $(0.29) Down From $0.49 YoY

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Why MindWalk Holdings Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket

Crude Oil Down 1%; AutoZone Shares Dip After Q1 Results

12 Health Care Stocks Moving In Tuesday's Intraday Session

Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial

Dow Surges Over 100 Points; Campbell's Posts Upbeat Earnings

Market-Moving News for December 9th

12 Health Care Stocks Moving In Friday's Pre-Market Session

Halper Sadeh LLC Encourages Exicure, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Exicure Says Ongoing Phase 2 Study Of Burixafor In Autologous Stem Cell Transplant For Multiple Myeloma Nears Key Readout

Exicure Highlights Recent Achievements and Near-term Strategic Priorities

Exicure, Inc. Reports Second Quarter 2025 Financial Results

Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements

Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant

Exicure, Inc. Reports First Quarter 2025 Financial Results

Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q

Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant

Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma

Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)

12 Health Care Stocks Moving In Tuesday's After-Market Session

Exicure, Inc. Reports Full Year 2024 Financial Results

Exicure, Inc. (Nasdaq: XCUR) Announces Issuance of New Patent in Australia

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.

Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech

Exicure Announces Shareholders Approve $8.7M Equity Financing From HiTron Systems

Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes

Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results

12 Health Care Stocks Moving In Thursday's Intraday Session

Why Exicure Shares Are Trading Higher By Around 180%; Here Are 20 Stocks Moving Premarket